Concepts in Onychomycosis Treatment and Recurrence Prevention: An Update.

Current and emerging options in the treatment of onychomycosis.

Currently approved options for the treatment of onychomycosis include systemic therapy (the antifungal agents fluconazole, itraconazole, and terbinafine), topical agents (ciclopirox, which has been available since 1996, efinaconazole, currently pending approval), and laser systems. Phase III studies on another topical, tavaborole, have been completed and this medication also shows promise. Mech...

An update on current concepts of the epidemiology of bovine Pestivirus infection in cattle

Onychomycosis: A Rare Presentation of Fungal Urinary Tract Infection in an Extremely Preterm Neonate

Onychomycosis refers to nail infections, caused by fungi including yeasts and non-dermatophyte moulds. One or several toenails or fingernails (seldom all) may be involved in this condition. Many cases of fingernail onychomycosis are due to yeasts. Fungal infection has emerged as an important cause of neonatal infection, associated with significant morbidity and mortality, especially in very low...

Update on the Treatment of Onychomycosis

Suggested scheme for the treatment of onychomycosis A stepped therapeutic approach to the treatment of onychomycosis is suggested. The risks of failure of treatment include the fungal involvement of the lunula portion, the lateral edge of the nail and the subungual area. Infection of the subungual area may lead to extensive onycholysis or dermatophytoma presenting as a hard subungual mass or as...

New pharmacotherapy for the treatment of onychomycosis: an update.

INTRODUCTION Onychomycosis is an infection of the nail plate that is an important priority area for the development of antifungal drugs. The high incidence of relapse and reinfection often makes onychomycosis a chronic condition. The current gold standard is oral therapy, but the development of effective topical agents remains a priority as they have fewer systemic interactions. AREAS COVERED...